Fund profile / United States

TCG Crossover Fund III

Geography
United States
Stage
Growth
Fund size
$1.3B
Focus
Biotech and Therapeutics
Signals
Published
Share
N°01 / About

About TCG Crossover Fund III

Life sciences, biotech, disruptive medicines, innovative therapies. Pre-IPO, crossover, public and private investments (flexible mandate).

N°02 / Thesis

Investment Focus

Location / RegionUnited States
Funding StageGrowth
Industry Focus
Biotech
Therapeutics

Investor Signals Profile

active

Sweet Spot

Biotech therapeutics founder targeting M&A with unmet needs

life sciences
biotech
therapeutics
M&A-focused
unmet medical needs

Bullish Signals

Signal text is part of a paid plan
Signal text is part of a paid plan
Signal text is part of a paid plan

Contrarian Signals

No contrarian signals recorded.

Founder Do's

Signal text is part of a paid plan
Signal text is part of a paid plan
Signal text is part of a paid plan

Founder Don'ts

No red flags recorded.

7 signals on TCG Crossover Fund III

3 bullish · 3 pitch do's · 1 GP profile, each with its source. From €9/month, cancel anytime.

Michael's Network

Facts

Fund Overview

Fund Size$1.3B
Saves0
People

Key People

Dr. Chen Yu, Cariad Chester, Giuliano Marostica

Cariad ChesterManaging Partner
N°04 / See also

Related Funds

Location
United States
Stage
Pre Seed
Focus
Deep Tech, Semiconductors, Ai Ml, Robotics Automation, Energy Tech, Biotech
Manager
Peter Barrett, Bruce Leak, Matt Hershenson, Andy Rubin
Pre Seed
Deep Tech
Semiconductors
Ai Ml
Robotics Automation
Energy Tech
Biotech
Location
United States
Stage
Seed
Focus
Fintech
Manager
Addie Lerner, Tali Vogelstein Miller, Rene Gendelman
Seed
Fintech
Location
United States
Stage
Seed
Focus
Web3 Finance, Fintech
Manager
Ben Jacobs, Greg d'Incelli
Seed
Web3 Finance
Fintech
Connect your agent Free to start. No key, no signup.